Archive for April 1, 2019
Life science and legislative convergence: 4 questions with Arbor Pharmaceutical CEO Ed Schutter
With the 2019 Georgia legislative session in full swing and potentially game changing recent comments from U.S. Health and Human Services Secretary Alex Azar, Paul Snyder, VP of Healthcare for Georgia Bio partner Write2Market spoke with Arbor Pharmaceutical CEO Ed Schutter about what the life sciences industry needs from state policy makers in 2019. Paul:…
Read MoreVideo Interview: “We are ultimately supporting our economy and our students in identifying high paying jobs in the life sciences sector.”
A state’s life science industry is only as robust as its available workforce. During the 2019 Georgia Bio Golden Helix Awards Gala, Chuck Fogelgren shared his thoughts on STEM education, public – private partnerships, precision medicine, data and the Georgia ecosystem. “[Our teacher training program] is specifically designed to help prepare these students to enter…
Read More